CUCCURULLO, Franco
 Distribuzione geografica
Continente #
NA - Nord America 11.144
EU - Europa 8.503
AS - Asia 7.923
SA - Sud America 899
AF - Africa 108
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 7
Totale 28.601
Nazione #
US - Stati Uniti d'America 10.964
SG - Singapore 2.934
CN - Cina 2.635
UA - Ucraina 1.694
IE - Irlanda 1.330
TR - Turchia 1.236
SE - Svezia 1.125
GB - Regno Unito 1.084
IT - Italia 1.007
BR - Brasile 760
FR - Francia 740
DE - Germania 607
IN - India 490
FI - Finlandia 358
VN - Vietnam 293
RU - Federazione Russa 254
CA - Canada 108
PL - Polonia 78
AR - Argentina 65
MX - Messico 53
BD - Bangladesh 48
ZA - Sudafrica 47
ES - Italia 44
BE - Belgio 43
JP - Giappone 40
IQ - Iraq 35
HK - Hong Kong 34
KR - Corea 34
CZ - Repubblica Ceca 29
NL - Olanda 27
EC - Ecuador 25
IL - Israele 23
RO - Romania 20
IR - Iran 19
ID - Indonesia 16
EU - Europa 15
PK - Pakistan 15
AT - Austria 14
CO - Colombia 14
GR - Grecia 14
KE - Kenya 13
MA - Marocco 13
LT - Lituania 12
VE - Venezuela 10
EG - Egitto 9
JO - Giordania 8
PY - Paraguay 8
UZ - Uzbekistan 8
DZ - Algeria 7
AE - Emirati Arabi Uniti 6
TN - Tunisia 6
AZ - Azerbaigian 5
CL - Cile 5
MY - Malesia 5
NO - Norvegia 5
SA - Arabia Saudita 5
AU - Australia 4
ET - Etiopia 4
KZ - Kazakistan 4
LB - Libano 4
OM - Oman 4
UY - Uruguay 4
AL - Albania 3
BN - Brunei Darussalam 3
HN - Honduras 3
HR - Croazia 3
MD - Moldavia 3
NP - Nepal 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
SR - Suriname 3
AO - Angola 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CU - Cuba 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
JM - Giamaica 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
CG - Congo 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
ML - Mali 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
Totale 28.591
Città #
Singapore 2.139
Jacksonville 1.808
Chandler 1.588
Dublin 1.317
Southend 777
Izmir 655
Princeton 636
Beijing 605
Dallas 520
Ashburn 511
Nanjing 501
Dearborn 418
Wilmington 373
Los Angeles 332
Cambridge 301
Tongling 245
The Dalles 239
Santa Clara 223
Chieti 222
Ann Arbor 212
Nanchang 192
New York 172
Woodbridge 167
Buffalo 162
Altamura 149
Boardman 135
Ho Chi Minh City 102
Shenyang 98
Tianjin 83
Council Bluffs 80
Hebei 80
Munich 80
São Paulo 78
Jiaxing 77
Houston 74
Grevenbroich 68
Hefei 62
Washington 62
Kunming 60
San Mateo 53
Warsaw 50
Brooklyn 47
Changsha 46
Hanoi 46
Hangzhou 43
Brussels 41
Milan 41
Tokyo 40
Augusta 39
Jinan 38
Stockholm 38
Johannesburg 37
Auburn Hills 36
Montreal 36
Orange 36
Toronto 36
Denver 35
Hong Kong 34
Redondo Beach 34
Chennai 33
Dong Ket 33
Rome 33
Helsinki 32
Leawood 32
Norwalk 31
Seoul 30
Moscow 29
Seattle 29
Pescara 28
Rio de Janeiro 28
Chicago 27
Guangzhou 27
Ningbo 27
Brno 26
London 25
Phoenix 25
Orem 24
Turku 24
Poplar 23
Atlanta 20
Boston 19
Falls Church 19
Manchester 19
Kraków 18
Tappahannock 18
Zhengzhou 17
Changchun 16
Mexico City 16
Querétaro 16
Lanzhou 15
San Francisco 15
Taizhou 15
Amsterdam 14
Da Nang 14
Frankfurt am Main 14
Mumbai 14
Ankara 13
Belo Horizonte 13
Curitiba 13
Haiphong 13
Totale 17.306
Nome #
Rimodellamento concentrico del ventricolo sx in pazienti con ipertensione essenziale: è un pattern geometrico omogeneo? 247
Ouabaina endogena, pattern emodinamico e geometria ventricolare sx nell'ipertensione essenziale. 196
13C Breath tests and cytosolic liver function. 169
Ascorbic acid supplementation reduces oxidative stress and platelet biochemical function in type 2 diabetic patients. Relevance of ascorbic acid dosage and formulation 162
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 153
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 151
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. 151
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 150
Allergen immunotherapy: an effective immune-modifier. 149
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 146
Blood cardioplegia: could it protect the ischemic-reperfused human myocardium through antioxidant-type mechanisms? 144
Aortic glutathione metabolic status: time-dependent alterations in fat-fed rabbits 142
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits. 141
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 141
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 140
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 139
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 139
'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care 136
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. 135
White-coat resistant hypertension 134
Calcium homeostasis in excitable cells exposed to ELF. 131
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 131
Additional Antihypertensive effect of fluvastatin in hypertensive and hypercholesterolemic patients treated with trandolapril. 129
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 129
Low density lipoprotein oxidation and antioxidant vitamins in dipper and nondipper hypertensive patients 128
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 128
Attività della paraoxonasi sierica in pazienti con ipertensione arteriosa essenziale. 127
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 127
AORTIC ANTIOXIDANT DEFENSE MECHANISMS IN RABBITS SUBJECTED TO SUPRARENAL AORTIC COARCTATION HYPERTENSION 127
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 127
Relationship between oxidative stress, monocyte activation and restenosis after coronary angioplasty. 126
Cardiovascular risk in patients receiving double therapy with false and true nonresponder hypertension. 126
Sensitivity disturbances in patients with irritable bowel syndrome and fibromyalgia 126
Ambroxol is a scavenger of hypochlorous acid and monochloramine 125
Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis. 125
Amiodarone inhibits tocopherol-mediated human lipoprotein peroxidation 123
Cephalosporins are scavengers of hypochlorous acid 123
Myocardial glutathione metabolic status in fat-fed rabbits 123
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 122
Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. 122
INCREASED TYPE I AND TYPEII TRANSFORMING GROWTH FACTOR-β RECEPTOR EXPRESSION DURING CHOLESTEROL CHALLENGE. 121
Blunted nocturnal fall in blood pressure and oxidative stress in men and women with essential hypertension. 121
Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. 121
Circulating leptin is associated with oxidized LDL in postmenopausal women. 120
Cigarette smoke, ferritin, and lipid peroxidation 120
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 119
Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium 119
A prospective evaluation of iron deficiency anemia in the GI endoscopy setting: role of standard endoscopy, videocapsule endoscopy, and CT-enteroclysis 119
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. 118
Heightened free radical activity in angina pectoris 118
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 118
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. 117
Association between 5-lipoxygenase expression and plaque instability in humans. 117
Alterazioni della parete vescicale in bambini affetti da enuresi notturna. 116
Low density lipoprotein oxidation in white coat and sustained hypertension (pubbl. su Am J Hypertension). 115
Ossidazione delle LDL e vitamine antiossidanti in pazienti ipertesi dipper e nondipper. 115
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 115
Int6 expression can predict survival in early-stage non-small cell lung cancer patients. 115
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 115
Vascular characteristic in hypertensive patients with different left ventricular morphology 114
Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques 114
Paraoxonase activity is significantly reduced in smokers. Effect of vitamin E supplementation 113
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 113
Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. 113
Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge 112
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 112
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 112
Ambulatory blood pressure monitoring in type 2 diabetes and metabolic syndrome: a review. 112
[Physiopathological bases of the medical treatment of portal hypertension]. 112
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 112
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 112
Blood pressure variability and cardiovascular risk in treated hypertensive patients. 112
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 112
Study of the gastric mucosal reactivity in patients with urticaria induced by nonsteroidal anti-inflammatory drugs. 111
Heparin: does it act as an antioxidant in vivo? 111
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 111
Morning blood pressure surge, dipping, and risk of ischemic stroke in elderly patients treated for hypertension 111
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 110
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. 110
Copper, zinc superoxide dismutase plus hydrogen peroxide: a catalytic system for human lipoprotein oxidation 110
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 110
Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension 109
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 109
Effect of ischaemia-reperfusion on glutathione peroxidase, glutathione reductase and glutathione transferase activities in human heart protected by hypothermic cardioplegia. 109
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 109
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 109
Left atrial enlargement and risk of ischemic stroke in elderly treated hypertensive patients 109
Ambulatory blood pressure stage 108
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 108
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 108
Prognostic value of different indices of blood pressure variability in hypertensive patients 108
PRAVASTATIN UP-REGULATES TGF-B1 IN THP-1 HUMAN MACROPHAGES :EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION 107
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 107
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 107
Correspondence - In Reply - Limitations of Single-Strand Conformation Polymorphism Analysis As a High-Throughput Method for the Detection of EGFR Mutations in the Clinical Setting 107
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. 107
Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. 106
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients 106
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 105
Effects of ischemia-reperfusion on the myocardial antioxidant defences in patients subjected to cardio-pulmonary bypass 105
Totale 12.331
Categoria #
all - tutte 113.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.183 0 0 0 0 0 404 20 8 226 303 104 118
2021/20221.408 79 20 17 315 149 16 20 104 114 37 154 383
2022/20234.241 348 509 238 548 403 885 264 290 526 50 101 79
2023/20241.783 142 65 128 46 94 532 457 62 16 43 11 187
2024/20254.745 335 810 632 58 106 156 88 216 454 211 600 1.079
2025/20264.820 884 436 944 1.211 892 453 0 0 0 0 0 0
Totale 29.060